Jump to content
Alma Sokolovic-Rasmussen

Gates Foundation to Grant $38 Million for Low-Cost Polio Vaccine

Recommended Posts

Fortune-9 May 2016:

Japan’s Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries.

As part of a global plan to eradicate the crippling disease, of which experts say the world could see the last case this year, countries will need to switch from using oral polio vaccine (OPV) to using so-called inactivated polio vaccine (IPV) to ensure the disease does not reappear.

Experts fear a substantial worldwide shortage of IPV once every country in the world is ready to make the switch, and polio eradication strategists have been looking at how to avert that shortfall by encouraging new manufacturers into the sector.

Read the full article on Fortune.com

Share this post


Link to post
Share on other sites

Please sign in to comment

You will be able to leave a comment after signing in



Sign In Now

×
×
  • Create New...